These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16479142)

  • 1. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of benign insulinoma using octreotide LAR: a case report.
    Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
    Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pasireotide for malignant insulinoma.
    Tirosh A; Stemmer SM; Solomonov E; Elnekave E; Saeger W; Ravkin Y; Nir K; Talmor Y; Shimon I
    Hormones (Athens); 2016 Apr; 15(2):271-276. PubMed ID: 26732164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of metastatic malignant insulinomas. 2 cases].
    Mounedji-Boudiaf L; Rougier P; Culine S; de Baere T; Lasser P; Escudier B; Ducreux M; Kaloustian E; Droz JP; Roche A
    Presse Med; 1995 May; 24(19):894-6. PubMed ID: 7638129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas.
    Nakamura A; Mitsuhashi T; Takano Y; Miyoshi H; Kameda H; Nomoto H; Nagai S; Hatanaka Y; Shimizu C; Terauchi Y; Atsumi T
    Endocr J; 2016; 63(2):135-42. PubMed ID: 26567922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant insulinoma in childhood.
    Karachaliou F; Vlachopapadopoulou E; Kaldrymidis P; Simatos G; Zacharea M; Spanidou-Karvouni E; Michalacos S; Voros D
    J Pediatr Endocrinol Metab; 2006 May; 19(5):757-60. PubMed ID: 16789643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors.
    Oda Y; Tanaka Y; Naruse T; Sasanabe R; Tsubamoto M; Funahashi H
    Surg Today; 2002; 32(8):690-4. PubMed ID: 12181718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
    Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
    Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections.
    Okamoto M; Kishimoto M; Takahashi Y; Osame K; Noto H; Yamamoto-Honda R; Kajio H; Tokuhara M; Edamoto Y; Endo H; Igari T; Kubota K; Noda M
    Endocr J; 2013; 60(8):951-7. PubMed ID: 23665775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of malignant insulin-producing pancreatic tumor treatment].
    Reutova EV; Orel NF; Besova NS; Artemova EV; Smirnova NB; Gorbunova VA
    Ter Arkh; 1999; 71(10):44-5. PubMed ID: 10612174
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible functional regression of insulinoma with prolonged octreotide.
    Craig CE; Gallen IW
    Postgrad Med J; 2002 Oct; 78(924):623-4. PubMed ID: 12415090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome.
    Novruzov F; Mehmetbeyli L; Aliyev JA; Abbasov B; Mehdi E
    Clin Nucl Med; 2019 Jun; 44(6):e415-e417. PubMed ID: 30789400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant insulinoma presenting as metastatic liver tumor. Case report and review of the literature.
    Baldelli R; Ettorre G; Vennarecci G; Pasimeni G; Carboni F; Lorusso R; Barnabei A; Appetecchia M
    J Exp Clin Cancer Res; 2007 Dec; 26(4):603-7. PubMed ID: 18365560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant insulinoma].
    Tóth M; Szücs N; Jakab Z; Doros A; Nemes Z; Rácz K
    Orv Hetil; 2011 Mar; 152(10):398-402. PubMed ID: 21354956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: case report and review of the literature.
    Moscetti L; Saltarelli R; Giuliani R; Fornarini G; Bezzi M; Cortesi E
    Tumori; 2000; 86(6):475-9. PubMed ID: 11218190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined octreotide and peptide receptor radionuclide therapy ((90)Y-DOTA-TATE) in case of malignant insulinoma.
    Fischbach J; Gut P; Matysiak-Grześ M; Klimowicz A; Gryczyńska M; Waśko R; Ruchała M
    Neuro Endocrinol Lett; 2012; 33(3):273-8. PubMed ID: 22635083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective therapy of insulinoma by using long-acting somatostatin analogue. A case report and literature review.
    Jawiarczyk A; Bolanowski M; Syrycka J; Bednarek-Tupikowska G; Kałużny M; Kołodziejczyk A; Domosławski P
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):68-72. PubMed ID: 22187292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.